TNFAIP2 Antibody | 33-012

TNFAIP2 Antibody | 33-012 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human

Homology: N/A

Immunogen: A recombinant protein fragment from the internal region of TNFAIP2 was used as the immunogen for this antibody.

Research Area: Cancer, Cell Cycle

Tested Application: WB

Application: Western blot: 4-8 ug/ml
Provided assay concentrations are suggestions only, TNFAIP2 antibody titration may be required for optimal results.

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Protein A affinity chromatography

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.1 mg/ml BSA and 0.05% sodium azide

Concentration: 0.5 mg/mL

Storage Condition: Aliquot and Store at -20˚C. Avoid freez-thaw cycles.

Alternate Name: TNFAIP2 Antibody: B94, EXOC3L3, Tumor necrosis factor alpha-induced protein 2, Primary response gene B94 protein, TNF alpha-induced protein 2

User Note: Optimal dilutions for each application to be determined by the researcher

BACKGROUND: TNFAIP2 tumor necrosis factor, alpha-induced protein 2 was originally referred to as B94, a TNFa primary response gene expressed in endothelial cells. It has subsequently been found to be involved with a number of different cancers. It is a promoter of nasopharyngeal cancer cell migration and has a genetic variant associated with head and neck cancer susceptibility. The aberrant expression of TNFAIP2 in the malignant cells of Hodgkin lymphoma and primary thymic large B-cell lymphoma may serve as a marker to distinguish them from other large B-cell lymphomas.